ETC
BSX icon

Exchange Traded Concepts’s Boston Scientific BSX Stock Holding History

Exchange Traded Concepts’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96M Sell
45,990
-21,411
-32% -$1.16M 0.01% 724
2026
Q1 		$4.23M Buy
67,401
+2,113
+3% +$169K 0.03% 435
2025
Q4 		$6.23M Buy
65,288
+625
+1% +$61.3K 0.05% 356
2025
Q3 		$6.31M Buy
64,663
+22,791
+54% +$2.36M 0.05% 329
2025
Q2 		$4.5M Buy
41,872
+30,824
+279% +$3.12M 0.06% 333
2025
Q1 		$1.11M Sell
11,048
-574
-5% -$57.8K 0.02% 524
2024
Q4 		$1.04M Sell
11,622
-1,035
-8% -$91.1K 0.02% 544
2024
Q3 		$1.06M Sell
12,657
-13,542
-52% -$1.07M 0.02% 481
2024
Q2 		$2.02M Buy
26,199
+361
+1% +$26.4K 0.05% 296
2024
Q1 		$1.77M Sell
25,838
-5,219
-17% -$336K 0.05% 308
2023
Q4 		$1.8M Sell
31,057
-8,028
-21% -$429K 0.05% 286
2023
Q3 		$2.06M Sell
39,085
-29,342
-43% -$1.54M 0.06% 234
2023
Q2 		$3.7M Buy
68,427
+34,508
+102% +$1.8M 0.09% 186
2023
Q1 		$1.7M Sell
33,919
-3,212
-9% -$151K 0.05% 234
2022
Q4 		$1.72M Sell
37,131
-4,065
-10% -$176K 0.05% 206
2022
Q3 		$1.6M Sell
41,196
-2,665
-6% -$107K 0.05% 176
2022
Q2 		$1.64M Sell
43,861
-7,061
-14% -$287K 0.05% 198
2022
Q1 		$2.25M Sell
50,922
-21,880
-30% -$948K 0.05% 208
2021
Q4 		$3.09M Sell
72,802
-10,211
-12% -$429K 0.06% 188
2021
Q3 		$3.6M Buy
83,013
+5,859
+8% +$259K 0.09% 149
2021
Q2 		$3.3M Buy
77,154
+1,763
+2% +$74.2K 0.1% 155
2021
Q1 		$2.91M Buy
75,391
+23,450
+45% +$888K 0.11% 139
2020
Q4 		$1.87M Buy
51,941
+35,676
+219% +$1.29M 0.09% 156
2020
Q3 		$621K Buy
16,265
+6,589
+68% +$254K 0.04% 251
2020
Q2 		$340K Buy
9,676
+5,298
+121% +$191K 0.06% 284
2020
Q1 		$143K Buy
4,378
+2,115
+93% +$82.6K 0.08% 227
2019
Q4 		$102K Buy
+2,263
New +$94.7K 0.02% 191

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Exchange Traded Concepts's BSX Position: Q2 2026 in Review

Exchange Traded Concepts reduced its Boston Scientific (BSX) stake by 32% in Q2 2026, selling an estimated $1.16M and leaving 45,990 shares worth $1.96M. The position accounts for 0.01% of the portfolio, ranked #724.

Exchange Traded Concepts first reported a position in BSX in Q4 2019 and has held it in 27 quarters since. The position peaked at $6.31M in Q3 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Exchange Traded Concepts held 45,990 shares of Boston Scientific worth $1.96M as of Q2 2026.
  • Exchange Traded Concepts sold 21,411 Boston Scientific shares in Q2 2026, an estimated $1.16M.
  • Boston Scientific made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #724 holding.
  • Exchange Traded Concepts first reported a position in Boston Scientific in Q4 2019 and has held it in 27 quarters since.
  • Exchange Traded Concepts's Boston Scientific position peaked at $6.31M in Q3 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.